Extendicare Inc
TSX:EXE

Watchlist Manager
Extendicare Inc Logo
Extendicare Inc
TSX:EXE
Watchlist
Price: 22.41 CAD 0.81%
Market Cap: 1.9B CAD

Intrinsic Value

The intrinsic value of one EXE stock under the Base Case scenario is 25.71 CAD. Compared to the current market price of 22.41 CAD, Extendicare Inc is Undervalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EXE Intrinsic Value
25.71 CAD
Undervaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Extendicare Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about EXE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is EXE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Extendicare Inc.

Explain Valuation
Compare EXE to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EXE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Extendicare Inc

Current Assets 276.9m
Cash & Short-Term Investments 165.7m
Receivables 88.8m
Other Current Assets 22.3m
Non-Current Assets 597m
Long-Term Investments 24m
PP&E 334.6m
Intangibles 198.5m
Other Non-Current Assets 39.9m
Current Liabilities 341.1m
Accounts Payable 308.9m
Other Current Liabilities 32.3m
Non-Current Liabilities 368.8m
Long-Term Debt 317.2m
Other Non-Current Liabilities 51.7m
Efficiency

Free Cash Flow Analysis
Extendicare Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Extendicare Inc

Revenue
1.6B CAD
Cost of Revenue
-1.4B CAD
Gross Profit
224.9m CAD
Operating Expenses
-94.2m CAD
Operating Income
130.7m CAD
Other Expenses
-39.7m CAD
Net Income
91m CAD
Fundamental Scores

EXE Profitability Score
Profitability Due Diligence

Extendicare Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROIC is Increasing
Exceptional ROIC
66/100
Profitability
Score

Extendicare Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

EXE Solvency Score
Solvency Due Diligence

Extendicare Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average Altman Z-Score
Positive Net Debt
Average Interest Coverage
47/100
Solvency
Score

Extendicare Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EXE Price Targets Summary
Extendicare Inc

Wall Street analysts forecast EXE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXE is 23.72 CAD with a low forecast of 19.19 CAD and a high forecast of 26.25 CAD.

Lowest
Price Target
19.19 CAD
14% Downside
Average
Price Target
23.72 CAD
6% Upside
Highest
Price Target
26.25 CAD
17% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EXE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one EXE stock?

The intrinsic value of one EXE stock under the Base Case scenario is 25.71 CAD.

Is EXE stock undervalued or overvalued?

Compared to the current market price of 22.41 CAD, Extendicare Inc is Undervalued by 13%.

Back to Top